Effect of xuesaitong soft capsule (Chinese characters) on hemorrheology and in auxiliarily treating patients with acute cerebral infarction

Chinese Journal of Integrative Medicine

Volumn 11, Issue 2, 2005, Pages 128-131

  Zhong, Shang Qian ^a   Sun, Li Jing ^a   Yan, Yu Zhen ^a   Sun, Yan Qin ^a   Zhong, Yin Yuan ^a  

^a Second People's Hospital of Liaocheng   (China)

Author keywords

Acute cerebral infarction; Hemorrheologic indexes; Nerve function deficits scoring; Xuesaitong soft capsule

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR; CITICOLINE; HERBACEOUS AGENT; MANNITOL; PIRACETAM; TROXERUTIN;

ADULT; AGED; ARTICLE; BLOOD RHEOLOGY; BRAIN INFARCTION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE FUNCTION; PRIORITY JOURNAL; THROMBOCYTE COUNT;

EID: 22144462418     PISSN: 16720415     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02836469     Document Type: Article

References (12)

1. Li LX, Wang ZC, Huang ZH, et al. Protective action of notoginseng saponins against acute cerebral ischemia. Chin Pharmacol Bull 1991; 7(1): 56-58.
2. Bai Y, Zhang SY, Ren J, et al. Multi-center study on the notoginseng saponin in treating cerebral infarction. Chin J New Drugs Clin Remedies 2001; 20(4): 257-259.
3. Dong L. Clinical observation on treatment of unstable angina pectoris by Xuesaitong soft capsule combined with low molecular heparin. Chin J Integr Tradit West Med (Chin) 2004; 24(9): 789.
4. Chen QT. Standard for scoring of clinical nerve function deficits in patients with stroke (1995). Chin J Neurol 1996; 29: (4): 381-383.
5. The international stroke trial: A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischemic stroke. Lancet 1997; 349: 1569-1581.
6. Chinese acute stroke trial: Randomized placebo-controlled trial of early aspirin use in 20000 patients with acute ischemic stroke. Lancet 1997; 349: 1641-1649.
7. Van de Wert F, Topol EJ, Lee KL, et al. Global utilization of stroptokinase and tissue plasminogen activator for occluded coronary arteries. JAMA 1995; 273: 1586-1591.
8. Gulati M, Patel S, Jaffe AS, et al. Impact of contemporary guideline compliance for acute coronary syndromes. Am J Cardiol 2004; 94: 873-878.
9. Ai WB, Chen YH, Yang WJ. Clinical observation on treatment of serious cranial trauma by Xuesaitong injection combined with western medicines. Chin J Integr Tradit West Med 2004;23(3):213-215.
10. Cheng GL, Xun Y, Lu YT, et al. Effect of notoginseng saponins on serum vascular endothelial growth factor in patients with acute cerebral infarction. Chin J New Drugs Clin Remedies 2003; 22(6): 350-353.
11. Zhang YG, Lin TP. Protective effects of total saponins of Panax ginseng on ischemia reperfusion injury in rats brain. Chin Pharm Toxicol 1994; 11: 7-9.
12. Li LX. Protective effect of notoginseng saponins on rabbits with acute cerebral ischemia. Chin J Neurol Psychiatry 1987; (20): 109.